How to Promote COVID-19 Vaccination in the Digital Media Age: The Persuasive Effects of News Frames and Argument Quality
Abstract
:1. Introduction
- Is the persuasive effect of the obligation frame significantly different from that of the rights frame?
- Does the argument quality of news information positively influence audiences’ willingness to be vaccinated?
- Are individualists more likely to be persuaded by news with high argument quality and a rights frame?
- Are collectivists more likely to be persuaded by news with high argument quality and an obligation frame?
2. Materials and Methods
2.1. Participants
2.2. Experimental Design and Stimulus Materials
2.3. Measurements
2.3.1. Manipulation Check
2.3.2. Individual–Collective Orientation
2.3.3. Vaccination Intention
2.3.4. Control Variables
2.4. Data Analysis Strategies
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Appendix A
Rights-Framed | Obligation-Framed |
---|---|
Low argument quality | Low argument quality |
The COVID-19 vaccine can stimulate the body to produce targeting antibodies, thus providing immunological protection to the vaccinated individual. The COVID-19 vaccines currently used in China are mainly inactivated vaccines. Inactivation is a common method of vaccine preparation in the international arena and is a mature and reliable means of classical vaccine development. It deprives the virus of infectivity and replication while retaining the response activity that can elicit human immunity. In China, COVID-19 vaccines are provided to the public free of charge and they can voluntarily choose to inoculate or not. The COVID-19 vaccination is solely based on the principles of informed consent and voluntariness. The COVID-19 vaccination is a citizen’s right, not a duty. It is recommended that the public actively participate in vaccination on the premise of informed consent and exclusion of contraindications to better protect the health of individuals. | The COVID-19 vaccine can stimulate the body to produce targeting antibodies, thus providing immunological protection to the vaccinated individual. The COVID-19 vaccines currently used in China are mainly inactivated vaccines. Inactivation is a common method of vaccine preparation in the international arena and is a mature and reliable means of classical vaccine development. It deprives the virus of infectivity and replication while retaining the response activity that can elicit human immunity. Maximizing vaccination and gradually building a herd immunity barrier is the inevitable choice for the future. Studies have shown that a vaccination rate of 70 to 80 percent is required to achieve herd immunity. Since the rate of vaccination among the population is a matter of public health and safety, getting the vaccines right at this stage is an individual’s duty and a contribution to their family, society, and country. It is recommended that the public actively participate in vaccination on the premise of informed consent and the exclusion of contraindications for collective and national interests. |
High argument quality | High argument quality |
The COVID-19 vaccine can stimulate the body to produce targeting antibodies, thus providing immunological protection to the vaccinated individual. The COVID-19 vaccines currently used in China are mainly inactivated vaccines. Inactivation is a common method of vaccine preparation in the international arena and is a mature and reliable means of classical vaccine development. It deprives the virus of infectivity and replication while retaining the response activity that can elicit human immunity. As of the end of January 2021, the cumulative number of reported COVID-19 vaccinations in China has exceeded 24 million doses, and no serious adverse reactions have been reported. According to clinical trial interim data, the protection rate of the COVID-19 vaccine in China is 79.34%, which means that vaccines can reduce the risk of infection by nearly 80% within a certain period. Clinical results show that about two weeks after the completion of the second dose of vaccination, the vaccinated population can produce sufficient protective antibodies, and the antibodies can still maintain a high level for more than six months. In China, COVID-19 vaccines are provided to the public free of charge and they can voluntarily choose to inoculate or not. The COVID-19 vaccination is solely based on the principles of informed consent and voluntariness. The COVID-19 vaccination is a citizen’s right, not a duty. It is recommended that the public actively participate in vaccination on the premise of informed consent and exclusion of contraindications to better protect the health of individuals. | The COVID-19 vaccine can stimulate the body to produce targeting antibodies, thus providing immunological protection to the vaccinated individual. The COVID-19 vaccines currently used in China are mainly inactivated vaccines. Inactivation is a common method of vaccine preparation in the international arena and is a mature and reliable means of classical vaccine development. It deprives the virus of infectivity and replication while retaining the response activity that can elicit human immunity. As of the end of January 2021, the cumulative number of reported COVID-19 vaccinations in China has exceeded 24 million doses, and no serious adverse reactions have been reported. According to clinical trial interim data, the protection rate of the COVID-19 vaccine in China is 79.34%, which means that vaccines can reduce the risk of infection by nearly 80% within a certain period. Clinical results show that about two weeks after the completion of the second dose of vaccination, the vaccinated population can produce sufficient protective antibodies, and the antibodies can still maintain a high level for more than six months. Maximizing vaccination and gradually building a herd immunity barrier is the inevitable choice for the future. Studies have shown that a vaccination rate of 70 to 80 percent is required to achieve herd immunity. Since the rate of vaccination among the population is a matter of public health and safety, getting the vaccines right at this stage is an individual’s duty and a contribution to their family, society, and country. It is recommended that the public actively participate in vaccination on the premise of informed consent and exclusion of contraindications for collective and national interests. |
References
- WHO. Emergency Response. Weekly Epidemiological Update on COVID-19—1 September 2023. Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---1-september-2023 (accessed on 20 September 2023).
- Msemburi, W.; Karlinsky, A.; Knutson, V.; Aleshin-Guendel, S.; Chatterji, S.; Wakefield, J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature 2023, 613, 130–137. [Google Scholar] [CrossRef] [PubMed]
- Lazarus, J.V.; Wyka, K.; White, T.M.; Picchio, C.A.; Rabin, K.; Ratzan, S.C.; Leigh, J.P.; Hu, J.; El-Mohandes, A. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat. Commun. 2022, 13, 3801. [Google Scholar] [CrossRef] [PubMed]
- Wang, X.; Chao, F.; Yu, G.; Zhang, K. Factors influencing fake news rebuttal acceptance during the COVID-19 pandemic and the moderating effect of cognitive ability. Comput. Hum. Behav. 2022, 130, 107174. [Google Scholar] [CrossRef] [PubMed]
- Fajar, J.K.; Sallam, M.; Soegiarto, G.; Sugiri, Y.J.; Anshory, M.; Wulandari, L.; Kosasih, S.A.P.; Ilmawan, M.; Kusnaeni, K.; Fikri, M.; et al. Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis. Vaccines 2022, 10, 1356. [Google Scholar] [CrossRef] [PubMed]
- Lim, J.; Moon, K.K. Political Ideology and Trust in Government to Ensure Vaccine Safety: Using a U.S. Survey to Explore the Role of Political Trust. Int. J. Environ. Res. Public Health 2023, 20, 4459. [Google Scholar] [CrossRef] [PubMed]
- Larson, H.J.; Jarrett, C.; Eckersberger, E.; Smith, D.M.; Paterson, P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine 2014, 32, 2150–2159. [Google Scholar] [CrossRef] [PubMed]
- Lane, S.; MacDonald, N.E.; Marti, M.; Dumolard, L. Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017. Vaccine 2018, 36, 3861–3867. [Google Scholar] [CrossRef] [PubMed]
- Zarocostas, J. How to fight an infodemic. Lancet 2020, 395, 676. [Google Scholar] [CrossRef]
- Holzmann-Littig, C.; Stadler, D.; Popp, M.; Kranke, P.; Fichtner, F.; Schmaderer, C.; Renders, L.; Braunisch, M.C.; Assali, T.; Platen, L.; et al. Locating Medical Information during an Infodemic: Information Seeking Behavior and Strategies of Health-Care Workers in Germany. Healthcare 2023, 11, 1602. [Google Scholar] [CrossRef]
- Bonilla Altera, D.; Cabassa, I.; Martinez-Garcia, G. A Tale of Two Audiences: Formative Research and Campaign Development for Two Different Latino Audiences, to Improve COVID-19 Prevention Behavior. Healthcare 2023, 11, 1819. [Google Scholar] [CrossRef]
- Okan, O.; Bollweg, T.M.; Berens, E.-M.; Hurrelmann, K.; Bauer, U.; Schaeffer, D. Coronavirus-Related Health Literacy: A Cross-Sectional Study in Adults during the COVID-19 Infodemic in Germany. Int. J. Environ. Res. Public Health 2020, 17, 5503. [Google Scholar] [CrossRef] [PubMed]
- Samal, J. Impact of COVID-19 infodemic on psychological wellbeing and vaccine hesitancy. Egypt. J. Bronchol. 2021, 15, 14. [Google Scholar] [CrossRef]
- Loomba, S.; de Figueiredo, A.; Piatek, S.J.; de Graaf, K.; Larson, H.J. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat. Hum. Behav. 2021, 5, 337–348. [Google Scholar] [CrossRef] [PubMed]
- Naeem, S.B.; Bhatti, R.; Khan, A.J.H.I.; Journal, L. An exploration of how fake news is taking over social media and putting public health at risk. Health Inf. Libr. J. 2021, 38, 143–149. [Google Scholar] [CrossRef] [PubMed]
- Wu, W.; Lyu, H.; Luo, J. Characterizing discourse about COVID-19 vaccines: A reddit version of the pandemic story. Health Data Sci. 2021, 2021, 9837856. [Google Scholar] [CrossRef] [PubMed]
- Waszak, P.M.; Kasprzycka-Waszak, W.; Kubanek, A. The spread of medical fake news in social media–the pilot quantitative study. Health Policy Technol. 2018, 7, 115–118. [Google Scholar] [CrossRef]
- Sweeny, K.; Melnyk, D.; Miller, W.; Shepperd, J.A. Information Avoidance: Who, What, When, and Why. Rev. Gen. Psychol. 2010, 14, 340–353. [Google Scholar] [CrossRef]
- Pavela Banai, I.; Banai, B.; Miklousic, I. Beliefs in COVID-19 conspiracy theories, compliance with the preventive measures, and trust in government medical officials. Curr. Psychol. 2022, 41, 7448–7458. [Google Scholar] [CrossRef]
- Chen, X.; McMaughan, D.J.; Li, M.; Kreps, G.L.; Ariati, J.; Han, H.; Rhoads, K.E.; Mahaffey, C.C.; Miller, B.M. Trust in and Use of COVID-19 Information Sources Differs by Health Literacy among College Students. Healthcare 2023, 11, 831. [Google Scholar] [CrossRef]
- Rzymski, P.; Borkowski, L.; Drąg, M.; Flisiak, R.; Jemielity, J.; Krajewski, J.; Mastalerz-Migas, A.; Matyja, A.; Pyrć, K.; Simon, K.J.V. The strategies to support the COVID-19 vaccination with evidence-based communication and tackling misinformation. Vaccines 2021, 9, 109. [Google Scholar] [CrossRef]
- Roozenbeek, J.; Schneider, C.R.; Dryhurst, S.; Kerr, J.; Freeman, A.L.; Recchia, G.; Van Der Bles, A.M.; Van Der Linden, S. Susceptibility to misinformation about COVID-19 around the world. R. Soc. Open Sci. 2020, 7, 201199. [Google Scholar] [CrossRef] [PubMed]
- Lockyer, B.; Islam, S.; Rahman, A.; Dickerson, J.; Pickett, K.; Sheldon, T.; Wright, J.; McEachan, R.; Sheard, L.; The Bradford Institute for Health Research COVID-19 Scientific Advisory Group. Understanding COVID-19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK. Health Expect. 2021, 24, 1158–1167. [Google Scholar] [CrossRef]
- Adekola, J.; Fischbacher-Smith, D.; Okey-Adibe, T.; Audu, J. Strategies to build trust and COVID-19 vaccine confidence and engagement among minority groups in Scotland. Int. J. Disaster Risk Sci. 2022, 13, 890–902. [Google Scholar] [CrossRef]
- Qasem, S.N.; Al-Sarem, M.; Saeed, F. An Ensemble Learning Based Approach for Detecting and Tracking COVID19 Rumors. Comput. Mater. Contin. 2022, 70, 1722–1747. [Google Scholar]
- Qaiser, A.; Hina, S.; Kazi, A.K.; Ahmed, S.; Asif, R. Fake News Encoder Classifier (FNEC) for Online Published News Related to COVID-19 Vaccines. Int. J. Intell. Syst. 2023, 37, 73–90. [Google Scholar] [CrossRef]
- Montagni, I.; Ouazzani-Touhami, K.; Mebarki, A.; Texier, N.; Schück, S.; Tzourio, C.; Confins Group. Acceptance of a COVID-19 vaccine is associated with ability to detect fake news and health literacy. J. Public Health. 2021, 43, 695–702. [Google Scholar] [CrossRef] [PubMed]
- Ye, W.; Li, Q.; Yu, S. Persuasive Effects of Message Framing and Narrative Format on Promoting COVID-19 Vaccination: A Study on Chinese College Students. Int. J. Environ. Res. Public Health 2021, 18, 9485. [Google Scholar] [CrossRef] [PubMed]
- Goffman, E. Frame Analysis: An Essay on the Organization of Experience; Harvard University Press: Cambridge, MA, USA, 1974. [Google Scholar]
- Benford, R.D.; Snow, D.A. Framing Processes and Social Movements: An Overview and Assessment. Annu. Rev. Sociol. 2012, 26, 611–639. [Google Scholar] [CrossRef]
- Scheff, T.J. The Structure of Context: Deciphering Frame Analysis. Sociol. Theory 2005, 23, 368–385. [Google Scholar] [CrossRef]
- Krantz, I.; Sachs, L.; Nilstun, T. Ethics and vaccination. Scand. J. Public Health 2004, 32, 172–178. [Google Scholar] [CrossRef]
- Giubilini, A. Vaccination ethics. Br. Med. Bull. 2020, 137, 4–12. [Google Scholar] [CrossRef] [PubMed]
- Giubilini, A.; Douglas, T.; Savulescu, J. The moral obligation to be vaccinated: Utilitarianism, contractualism, and collective easy rescue. Med. Health Care Philos. 2018, 21, 547–560. [Google Scholar] [CrossRef] [PubMed]
- Lin, T.-C.; Hwang, L.-L.; Lai, Y.-J. Effects of argument quality, source credibility and self-reported diabetes knowledge on message attitudes: An experiment using diabetes related messages. Health Inf. Libr. J. 2017, 34, 225–235. [Google Scholar] [CrossRef] [PubMed]
- Li, C.-Y. Persuasive messages on information system acceptance: A theoretical extension of elaboration likelihood model and social influence theory. Comput. Hum. Behav. 2013, 29, 264–275. [Google Scholar] [CrossRef]
- Boller, G.W.; Swasy, J.L.; Munch, J.M. Conceptualizing Argument Quality Via Argument Structure. Adv. Consum. Res. 1990, 17, 321–328. [Google Scholar]
- Srivastava, V.; Kalro, A.D. Enhancing the Helpfulness of Online Consumer Reviews: The Role of Latent (Content) Factors. J. Interact. Mark. 2019, 48, 33–50. [Google Scholar] [CrossRef]
- Yuan, J.; Lam, W.W.T.; Xiao, J.; Ni, M.Y.; Cowling, B.J.; Liao, Q. Why do Chinese older adults in Hong Kong delay or refuse COVID-19 vaccination? A qualitative study based on Grounded Theory. J. Gerontol. Ser. B 2023, 78, 736–748. [Google Scholar] [CrossRef]
- Darwish, A.-F.E.; Huber, G.L. Individualism vs. collectivism in different cultures: A cross-cultural study. Intercult. Educ. 2003, 14, 47–56. [Google Scholar] [CrossRef]
- Driskell, J.E.; Salas, E.; Hughes, S. Collective Orientation and Team Performance: Development of an Individual Differences Measure. Hum. Factors 2010, 52, 316–328. [Google Scholar] [CrossRef]
- İmamoğlu, E.O. Individualism and collectivism in a model and scale of balanced differentiation and integration. J. Psychol. 1998, 132, 95–105. [Google Scholar] [CrossRef]
- Hofstede, G.; Bond, M.H. Hofstede’s culture dimensions: An independent validation using Rokeach’s value survey. J. Cross Cult. Psychol. 1984, 15, 417–433. [Google Scholar] [CrossRef]
- Triandis, H.C.; Gelfand, M.J. Converging measurement of horizontal and vertical individualism and collectivism. J. Pers. Soc. Psychol. 1998, 74, 118–128. [Google Scholar] [CrossRef]
- Earley, P.C. East meets West meets Mideast: Further explorations of collectivistic and individualistic work groups. Acad. Manag. J. 1993, 36, 319–348. [Google Scholar] [CrossRef]
- Van Der Wurff, R.; Schönbach, K. Between profession and audience: Codes of conduct and transparency as quality instruments for off-and online journalism. Journal. Stud. 2011, 12, 407–422. [Google Scholar] [CrossRef]
- Chadha, K.; Koliska, M. Newsrooms and transparency in the digital age. Journal. Pract. 2015, 9, 215–229. [Google Scholar] [CrossRef]
- Vos, T.P.; Craft, S. The discursive construction of journalistic transparency. Journal. Stud. 2017, 18, 1505–1522. [Google Scholar] [CrossRef]
- Hu, Y.; Shyam Sundar, S. Effects of online health sources on credibility and behavioral intentions. Commun. Res. 2010, 37, 105–132. [Google Scholar] [CrossRef]
- Ricco, R.B. The influence of argument structure on judgements of argument strength, function, and adequacy. Q. J. Exp. Psychol. 2008, 61, 641–664. [Google Scholar] [CrossRef]
- Petty, R.E.; Cacioppo, J.T.; Kasmer, J.A. The role of affect in the elaboration likelihood model of persuasion. In Communication, Social Cognition, and Affect (PLE: Emotion); Psychology Press: London, UK, 2015. [Google Scholar]
- Inglehart, R. Modernization, postmodernization and changing perceptions of risk. Int. Rev. Sociol. 1997, 7, 449–459. [Google Scholar] [CrossRef]
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2021, 27, 354. [Google Scholar] [CrossRef]
- Matsumoto, D. Culture, Context, and Behavior. J. Pers. 2007, 75, 1285–1320. [Google Scholar] [CrossRef]
- Carter, R.T. Cultural Values: A Review of Empirical Research and Implications for Counseling. J. Couns. Dev. 1991, 70, 164–173. [Google Scholar] [CrossRef]
Characteristic | Sample Size | Percentage | |
---|---|---|---|
Gender | Male | 115 | 37.1% |
Female | 195 | 62.9% | |
Age | 18–20 | 66 | 21.3% |
21–30 | 176 | 56.8% | |
31–40 | 47 | 15.2% | |
41 years and above | 21 | 6.8% | |
Organizational requirement | Yes | 77 | 24.8% |
No | 233 | 75.2% |
High Argument Quality | Low Argument Quality | |||
---|---|---|---|---|
Rights Frame | Obligation Frame | Rights Frame | Obligation Frame | |
Individualism | M = 4.30 | M = 3.55 | M = 3.36 | M = 3.02 |
SD = 0.60 | SD = 0.76 | SD = 1.04 | SD = 0.54 | |
Collectivism | M = 3.58 | M = 3.42 | M = 2.79 | M = 3.22 |
SD = 1.10 | SD = 0.91 | SD = 0.70 | SD = 0.54 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chen, X.; Wang, Y.; Huang, Y.; Wang, Z.; Shen, C. How to Promote COVID-19 Vaccination in the Digital Media Age: The Persuasive Effects of News Frames and Argument Quality. Systems 2023, 11, 491. https://doi.org/10.3390/systems11100491
Chen X, Wang Y, Huang Y, Wang Z, Shen C. How to Promote COVID-19 Vaccination in the Digital Media Age: The Persuasive Effects of News Frames and Argument Quality. Systems. 2023; 11(10):491. https://doi.org/10.3390/systems11100491
Chicago/Turabian StyleChen, Xi, Yan Wang, Yixin Huang, Zhenyuan Wang, and Chaohai Shen. 2023. "How to Promote COVID-19 Vaccination in the Digital Media Age: The Persuasive Effects of News Frames and Argument Quality" Systems 11, no. 10: 491. https://doi.org/10.3390/systems11100491
APA StyleChen, X., Wang, Y., Huang, Y., Wang, Z., & Shen, C. (2023). How to Promote COVID-19 Vaccination in the Digital Media Age: The Persuasive Effects of News Frames and Argument Quality. Systems, 11(10), 491. https://doi.org/10.3390/systems11100491